BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2022
View Archived Issues
Modulating CYTOR promotes myogenesis in aging
Read More
TGFBR3L modulates FSH activity and fertility
Read More
Hemagglutinin anchor epitope unveiled as a target of broadly neutralizing antibodies
Read More
Compact cell classifiers packaged into AAV vectors for precision tumor cell targeting
Read More
MRSA superbug has prickly origins
Read More
French researchers patent new antibacterial compounds
Read More
Janssen Pharmaceutica discloses Mcl-1 inhibitors
Read More
Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors
Read More
Chinese researchers describe new GLP-1 receptor agonists
Read More
Life Biosciences to accelerate R&D activities on aging-related programs
Read More
Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles
Read More
Discovery of novel bergenin derivatives as immunosuppressive agents
Read More
Wigen Biomedicine Technology synthesizes new Wee1 inhibitors
Read More
RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies
Read More
Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206
Read More
SalioGen obtains funding to advance research into genetic therapy for cystic fibrosis
Read More
Series A financing at ONK Therapeutics to support NK cell therapies through IND-enabling studies
Read More
Biomea's menin inhibitor BMF-219 normalizes glucose levels in animal models of type 2 diabetes
Read More
JUVA-019 enters preclinical development for inflammatory disease
Read More
LA-PAMAM/pmiR-218 polyplex as potential targeted gene therapy against HCC
Read More
Enanta expands respiratory virology program with EDP-323 for RSV
Read More
Regulating fibrin-neutrophil interaction for controlling periodontitis
Read More
Unity Biotechnology eyes IND-enabling studies with pipeline programs in 2022
Read More